½ÃÀ庸°í¼­
»óǰÄÚµå
1794012

¼¼°èÀÇ Æ÷ÀÎÆ® ¿Àºê Äɾî(POC) ¼Òº¯ °Ë»ç ¹× ¿ä³» ³²¿ë ¾à¹° °Ë»ç ½ÃÀå(2025³â)

Point-of-Care (POC) Urinalysis and Urinalysis Drugs of Abuse Testing Market, 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Kalorama Information | ÆäÀÌÁö Á¤º¸: ¿µ¹® 42 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

' ¼¼°èÀÇ Æ÷ÀÎÆ® ¿Àºê Äɾî(POC) ¼Òº¯ °Ë»ç ¹× ¿ä³» ³²¿ë ¾à¹° °Ë»ç ½ÃÀå(2025³â)' Àº Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ¼Òº¯ °Ë»ç ¹× ³²¿ë ¾à¹° °Ë»ç ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çß½À´Ï´Ù. ÇöÀç ½ÃÀå ¿ªÇÐ, ±â¼ú µ¿Çâ, ÇâÈÄ ¼ºÀå °¡´É¼ºÀ» Á¶»çÇÏ¿© 2029³â±îÁöÀÇ ¼öÀͰú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.

Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç´Â º´¿ø, ÀÇ¿ø, ¼Ò¸Å Ŭ¸®´Ð, °¡Á¤, °£º´ ½Ã¼³, Á÷Àå, ±º»ç ½Ã¼³ µî Áß¾Ó ÁýÁßÇü °Ë»ç ½Ã¼³ ÀÌ¿ÜÀÇ È¯ÀÚ ±Ùó¿¡¼­ ½Ç½ÃµÇ´Â Áø´Ü ÀýÂ÷¸¦ Æ÷ÇÔÇÕ´Ï´Ù. POC °Ë»ç´Â Á¾Á¾ ºñ°Ë»ç½Ç Á÷¿ø¿¡ ÀÇÇØ ¼öÇàµÇ¸ç, µö ½ºÆ½, ½ºÆ®¸³, ·¡ÅÍ·² Ç÷οì Ä«¼¼Æ® µîÀÇ ¼öµ¿ ±â¼ú°ú ¼ÒÇüÈ­ ¹× ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º °øÇÐÀÇ Áøº¸·Î °¡´ÉÇØÁø ÈÞ´ë¿ë, ÈÞ´ë¿ë, ÄÄÆÑÆ®ÇÑ Å¹»ó Àåºñ¸¦ ¸ðµÎ Ȱ¿ëÇÕ´Ï´Ù.

¼Òº¯°Ë»ç´Â POC ºÐ¾ß¿¡¼­ Áß½ÉÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ´ë»çÀå¾Ö, ½ÅÀ庴, ¹æ±¤¾Ï, ¿ä·Î °¨¿°Áõ µîÀÇ °Ç°­ ½ºÅ©¸®´×, Áø´Ü, ¸ð´ÏÅ͸µ µîÀÇ ¿ëµµ·Î ½Ã±â ÀûÀýÇÑ ÀÓ»ó ÆÇ´ÜÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¼Òº¯ °Ë»ç´Â ³²¿ë ¾à¹° °Ë»ç¿¡µµ ³Î¸® »ç¿ëµÇ¸ç ¹ý ÁýÇà ±â°ü, Çü»ç »ç¹ý, Á÷Àå ¹× ¸ÅÀå ä³Î¿¡¼­ ³ôÀº ¼ö¿ä°¡ ÀÖÀ¸¸ç POC ½ÃÀåÀÇ »ó´çÇÑ Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ä´¢°¡ ºñħ½ÀÀûÀ̶ó´Â °ÍÀº ºÐ»êÇü ¹× ÀÚü °Ë»ç ¿ëµµ¿¡ ´ëÇÑ Ã¤¿ë¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, µö½ºÆ½ ¼Òº¯ °Ë»ç´Â ¼¼°è¿¡¼­ °¡Àå ÆÇ¸Å·®ÀÌ ¸¹Àº POC °Ë»ç°¡ µÇ¾ú½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼ °¡Áö ÁÖ¿ä ÀåÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

  • POC ¼Òº¯ ½ºÆ®¸³ °Ë»ç
  • POC ¾à¹° ³²¿ë °Ë»ç
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ - OTC, POC ¹× ±âŸ ü¿Ü Áø´Ü¿ë ÀǾàǰ °³¹ß ¹× ¸¶ÄÉÆÃ¿¡ Á¾»çÇÏ´Â ¼±µµ ±â¾÷ ¹× Àü¹® ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ±Ô¸ð¿Í ¿¹ÃøÀº 2024³â ±âÁØÀ¸·Î ÇöÀç ´Þ·¯·Î Ç¥½ÃµË´Ï´Ù. ºÐ¼®Àº ¾÷°è Àü¹®°¡¿ÍÀÇ ÀÎÅͺä, ±â¾÷ µ¥ÀÌÅÍ, Á¤ºÎ °£Ç๰, »ê¾÷ Á¤º¸, ºÐ¼®°¡ º¸°í¼­ µî ±¤¹üÀ§ÇÑ 1Â÷ ¹× 2Â÷ Á¶»ç¿¡ ÀÇÇØ µÞ¹ÞħµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ¼Òº¯ ½ºÆ®¸³ °Ë»ç

  • ¼Ò°³
  • Á¦Ç°
  • POC ¼Òº¯ °Ë»çÀÇ µ¿Çâ
    • µðÁöÅÐ Çõ½ÅÀÌ °¡¼ÓÇÏ´Â º¯È­
    • »óȯ °úÁ¦¿¡ ´ëÇÑ ´ëó
    • ¼ÒºñÀÚÀÇ °Ç°­°ú DTC(Direct-to-Consumer)ÀÇ µ¿Çâ
    • OEM°ú À¯Åë¾÷ü°¡ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´ç
    • µ¥ÀÌÅÍ ÅëÇÕ Àå¾Ö
    • ÀÎÀç¿Í ¿¬¼öÀÇ ºÎÁ·
  • ½ÃÀå ±Ô¸ð¿Í ¼ºÀå
  • °æÀï ±¸µµ

Á¦3Àå ³²¿ë ¾à¹° °Ë»ç

  • ¼Ò°³
  • ³²¿ë ¾à¹° ¼Òº¯ °Ë»ç
  • ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦4Àå ½ÃÀå °æÀï»ç

  • ¼Ò°³
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • 77 Elektronika
    • Abbott
    • ACON Laboratories
    • Arkray
    • Cardinal Health
    • Healthy.io
    • QuidelOrtho
    • Roche
    • Siemens
    • Sysmex
    • Teco Diagnostics
JHS 25.08.28

Kalorama Information's "Point-of-Care (POC) Urinalysis and Urinalysis Drugs of Abuse Testing Market, 2025" provides an in-depth analysis of the global market for point-of-care urinalysis and drugs of abuse testing. The report examines current market dynamics, technological trends, and future growth potential, with revenue forecasts through 2029.

Point-of-care testing encompasses diagnostic procedures performed near the patient, outside centralized laboratory settings, including hospitals, physician offices, retail clinics, homes, nursing facilities, workplaces, and military locations. POC testing is often conducted by non-laboratory personnel and leverages both manual technologies-such as dipsticks, strips, and lateral flow cassettes-and portable, handheld, and compact benchtop instruments enabled by advances in miniaturization and microfluidics.

Urine testing plays a central role in the POC segment, supporting timely clinical decision-making for applications including health screening, diagnosis, and monitoring of metabolic disorders, kidney disease, bladder cancer, urinary tract infections, and other conditions. Urinalysis is also widely used in drugs of abuse testing, which commands a substantial share of the POC market with high demand across law enforcement, criminal justice, workplace, and over-the-counter channels. The non-invasive nature of urine collection has contributed to its adoption for decentralized and self-testing applications, making dipstick urinalysis the highest-volume POC test worldwide.

The report is organized into three key chapters:

  • POC Urine Strip Testing
  • POC Drug-of-Abuse Testing
  • Company Profiles - profiling both major and specialized firms engaged in OTC, POC, and other IVD product development and marketing.

Market size and forecasts are expressed in current U.S. dollars, based on 2024 as the base year. The analysis is supported by extensive primary and secondary research, incorporating industry expert interviews, company data, government publications, trade sources, and analyst reports.

Table of Contents

Chapter 1: Executive Summary

  • About Kalorama Information
  • Scope and Methodology
  • Overview of POC Testing
  • POC Urine Testing
  • Size and Growth of the Market
    • Table 1-1: POC Urinalysis Market, by Segment, 2024-2029 ($ million) [Drugs-of-abuse (POC professional, POC home/on-site), Health/screening (POC professional, POC self-test)]
    • Figure 1-1: POC Urinalysis Market, by Segment, 2024-2029 ($ million) [Drugs-of-abuse (POC professional, POC home/on-site), Health/screening (POC professional, POC self-test)]
    • Figure 1-2: POC Urinalysis Market Share, by Segment, 2024 (%) [Drugs-of-abuse (POC professional, POC home/on-site), Health/screening (POC professional, POC self-test)]
    • POC Professional Testing
    • POC Self-Testing
  • Trends in POC Urinalysis
  • Leading Competitors

Chapter 2: POC Urine Strip Testing

  • Introduction
  • Products
    • Table 2-1: Selected Urinalysis Systems, 2025
    • Table 2-2: Selected Urinalysis Innovations
  • Trends in POC Urinalysis
    • Digital Innovations Driving Accelerated Change
    • Addressing Reimbursement Challenges
    • Consumer Wellness and Direct-to-Consumer (DTC) Trends
    • OEMs and Distributors Playing a Major Role
    • Obstacles to Data Integration
    • Human Resource and Training Deficits
  • Market Size and Growth
    • Table 2-3: Global Health/Screening POC Urinalysis Market Forecast, by Segment, 2024-2029 ($ million) [POC professional, POC self-test]
    • Figure 2-1: Global Health/Screening POC Urinalysis Market Forecast, by Segment, 2024-2029 ($ million) [POC professional, POC self-test]
    • Figure 2-2: Global Health/Screening POC Urinalysis Market Share, by Segment, 2024-2029 (%) [POC professional, POC self-test]
  • Competitive Landscape
    • Table 2-4: Global Health/Screening POC Urinalysis Market, Estimated Market Shares and Revenues of Leading Suppliers, 2024 ($ million) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
    • Figure 2-3: Global Health/Screening POC Urinalysis Market, Revenues of Leading Suppliers, 2024 ($ million) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
    • Figure 2-4: Global Health/Screening POC Urinalysis Estimated Market Share, by Leading Suppliers, 2024 (%) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]

Chapter 3: POC Drug-of-Abuse Testing

  • Introduction
  • Drug-of-Abuse Urine Testing
  • Market Size and Growth
    • Table 3-1: Global POC Drug-of-Abuse Urinalysis Market Forecast, 2024-2029 ($ million) [POC professional, POC home/on-site]
    • Figure 3-1: Global POC Drug-of-Abuse Urinalysis Market Forecast, 2024-2029 ($ million) [POC professional, POC home/on-site]
    • Figure 3-2: Global POC Drug-of-Abuse Urinalysis Market Share, 2024-2029 (%) [POC professional, POC home/on-site]

Chapter 4: Market Competitors

  • Introduction
  • Company Profiles
    • 77 Elektronika
    • Abbott
    • ACON Laboratories
    • Arkray
    • Cardinal Health
    • Healthy.io
    • QuidelOrtho
    • Roche
    • Siemens
    • Sysmex
    • Teco Diagnostics
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦